Bronchiectasis associated with cystic fibrosis (CF) is well characterized, but the role of partial CFTR dysfunction in patients with non-CF bronchiectasis remains less clear. Patients with ...

"This is a great first step, even if it’s not perfect," says Elizabeth Kazarian, MD. "We’ll hold the system accountable and ...

Nirsevimab was associated with protective effects for infants in the first—but not the second—year after administration.

Ted Dawson, MD, PhD, discusses the factors driving the rising prevalence of major motor neurodegenerative diseases.

Joanna Tsai, MD, and Stuart C. Ray, MD, discuss how to diagnose and treat bacterial and fungal co- and superinfections.

Yvette C. Terrie, RPh, BS Pharm, discusses the clinical potential of the first triple reuptake inhibitor for ADHD.

The following is a summary of “Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: a data-driven analysis of randomised trials,” published in the March 2025 ...

Antipsychotic-induced hyperprolactinemia is another important consideration. Elevated prolactin can suppress ovarian hormone ...

Permanent pacing is the therapy of choice for treating severe and/or symptomatic bradyarrhythmias. The number of very elderly patients receiving pacemakers is increasing and little is known about ...

New data show surgical volume for patients with a BMI of 50 kg/m² and higher has declined significantly over time, despite ...